Financials
- Market Capitalization 106.01 M
- Employee 21
- Founded 2014
- CEO N/A
- Website www.blackdiamondtherapeutics.com
- Headquarter Massachusetts, United States
- FIGI BBG00MS4Y0W9
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
-2.84
Preis-Umsatz-Verhältnis
—
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3943 | ANIX Anixa Biosciences, Inc. - Common Stock | 3.35 USD | +5.02% | +10.20% | +29.84% | +4.04% | 113.98 M USD | ||
| 3946 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.51 USD | -0.88% | -2.80% | +2.50% | -55.91% | 107.30 M USD | ||
| 3958 | ICCC ImmuCell Corporation - Common Stock | 11.40 USD | -2.73% | +7.85% | +19.75% | +79.81% | 103.13 M USD | ||
| 3976 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.85 USD | -1.35% | -11.36% | +0.34% | -2.82% | 100.50 M USD |